Financhill
Sell
37

STRO Quote, Financials, Valuation and Earnings

Last price:
$0.74
Seasonality move :
0.48%
Day range:
$0.81 - $0.91
52-week range:
$0.52 - $5.17
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.01x
P/B ratio:
1.64x
Volume:
1.2M
Avg. volume:
2.1M
1-year change:
-80.73%
Market cap:
$68.8M
Revenue:
$62M
EPS (TTM):
-$2.98

STRO Analysts' Consensus Rating

The 9 analysts providing 12-month price projections for Sutro Biopharma shares anticipate an average target of $3.29, ranging from a low estimate of $1.00 to a high estimate of $7.00. This average target implies a growth of 303.11% compared to the current stock price of $0.82.

Consensus Price Target

$3.29

Highest Price Target

$7.00

Lowest Price Target

$1.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 7 4 4

Hold 1 6 5

Sell 0 0 0
Consensus Buy Hold Hold

STRO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Which Stocks Are Recession-Proof?
Which Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Is Gartner a Safe Stock to Own?
Is Gartner a Safe Stock to Own?

Gartner (NYSE:IT) is among the world’s largest consulting, research and…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
57
RGC alert for May 14

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
54
HALO alert for May 14

Halozyme Therapeutics [HALO] is down 4.84% over the past day.

Buy
91
COIN alert for May 14

Coinbase Global [COIN] is up 1.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock